Funded Tech Companies
Triplet Therapeutics
Triplet Therapeutics is a leading biopharmaceutical growth company, based in Cambridge. Venture capital investment was provided by Pfizer Venture Investments, Alexandria Venture Investments and Invus.
Company Overview
Company Name
Triplet Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Kendall Sq. 1400W 14201
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Our mission is to prevent repeat expansion disorders and ensure a future for our patients. We are developing a fundamentally different treatment for repeat expansion disorders -- including Huntington's disease, myotonic dystrophy and spinocerebellar ataxias -- by addressing the underlying cause of the genetic dysfunction that drives disease onset and progression.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/18/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nessan Bermingham
Chief Financial Officer
Eric Sullivan
Vice President
Brian Bettencourt
Vice President
Salma Kiani
VP - Bus. Development
Irina Antonijevic
VP - Engineering
David Morrissey
VP - General Counsel
Jeffrey Cerio
VP - Human Resources
Amy Lurier
VP - Operations
John Cavanaugh
Company Investors
- Pfizer Venture Investments (Laszlo Kiss)
- Alexandria Venture Investments
- Invus
- Atlas Venture (Nessan Bermingham)
- MPM Capital (Shinichiro Fuse)
- Partners Innovation Fund
Browse more funded tech companies:
Tripleseat Software | Triplingo
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs